polySUMO2,3-TOP2A [nucleoplasm]

Stable Identifier
R-HSA-4641298
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
DNA topoisomerase 2-alpha ecNumber5.99.1.3/ecNumber, TOP2A_HUMAN
Locations in the PathwayBrowser for interactor UniProt:P13010 XRCC5
Literature References
PubMed ID Title Journal Year
18394993 Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha

van Deursen, JM, Shuai, K, Kao, E, Jeganathan, KB, Tahk, S, Malureanu, L, Dawlaty, MM, Sustmann, C, Grosschedl, R

Cell 2008
18381449 Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity

Rino, J, Santos, V, Pinheiro, I, Hay, RT, Jaffray, E, Costa, R, Ferreira, F, Cardoso, J, Ferreira, J, Agostinho, M

Cancer Res. 2008
24782567 Proteome-wide identification of SUMO2 modification sites

Tatham, MH, Hay, RT, Tammsalu, T, Ibrahim, AF, Jaffray, EG, Matic, I

Sci Signal 2014
25114211 Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli

Impens, F, Cossart, P, Radoshevich, L, Ribet, D

Proc. Natl. Acad. Sci. U.S.A. 2014
External Reference Information
External Reference
Gene Names
TOP2A, TOP2
Chain
chain:1-1531
Reference Transcript
Other Identifiers
11720970_at
11720971_at
11720972_at
1592_at
16844312
201291_PM_s_at
201291_s_at
201292_PM_at
201292_at
3756157
3756194
3756195
3756196
3756197
3756198
3756199
3756200
3756201
3756202
3756203
3756204
3756205
3756206
3756207
3756208
3756209
3756210
3756211
3756212
3756213
3756214
3756215
3756216
3756217
3756218
3756219
3756220
3756221
3756222
3756223
3756224
3756225
3756226
3756227
3756228
3756229
3756230
3756231
3756232
3756233
3756234
3756235
40145_at
7153
74096_at
8014974
904_s_at
A_23_P118834
GE57498
GO:0000166
GO:0000228
GO:0000287
GO:0000712
GO:0000775
GO:0000793
GO:0000819
GO:0001673
GO:0002244
GO:0003677
GO:0003682
GO:0003723
GO:0003824
GO:0003916
GO:0003918
GO:0005080
GO:0005515
GO:0005524
GO:0005634
GO:0005654
GO:0005694
GO:0005730
GO:0005737
GO:0005814
GO:0005815
GO:0005856
GO:0006259
GO:0006265
GO:0006266
GO:0006310
GO:0006351
GO:0006355
GO:0006974
GO:0007059
GO:0007143
GO:0008094
GO:0008301
GO:0009330
GO:0012501
GO:0016853
GO:0022414
GO:0030154
GO:0030261
GO:0030263
GO:0032991
GO:0040016
GO:0042752
GO:0042803
GO:0043065
GO:0043130
GO:0043226
GO:0045870
GO:0045944
GO:0046872
GO:0046982
GO:0048511
GO:0048856
GO:0140013
GO:0140097
GO:0140657
GO:1905463
GO:1990904
HMNXSV003030322
Hs.156346.0.S1_3p_a_at
Hs.156346.0.S3_3p_at
ILMN_1686097
J04088_at
L47276_s_at
PH_hs_0009437
TC17001462.hg
TC17002618.hg
Participates
Other forms of this molecule
Inferred To
Modified Residues
Name
sumoylated lysine (polySUMO2,3 [nucleoplasm]) at unknown position
Modification
polySUMO2,3 [nucleoplasm]
PsiMod Name
PsiMod Definition
A protein modification that effectively crosslinks the N6-amino of a peptidyl lysine with the carboxyl-terminal glycine of a sumo (Small Ubiquitin-related MOdifier) protein.
Cross References
RefSeq
ZINC - World Drugs
Guide to Pharmacology - Targets
OpenTargets
ZINC - FDA approved
ZINC - Substances
ZINC target
ZINC - Biogenic
PRO
ZINC - Metabolites
GeneCards
Pharos - Targets
ZINC - Predictions - Purchasable
HMDB Protein
Interactors (18)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:Q05655 PRKCD  12 0.679 10
 UniProt:P13010 XRCC5  4 0.597 3
 UniProt:P09874 PARP1  4 0.597 4
 UniProt:P78527 PRKDC  4 0.597 3
 UniProt:P11387 TOP1  2 0.597 4
 UniProt:P35222 CTNNB1  20 0.57 5
 UniProt:Q9NR30 DDX21  1 0.564 3
 UniProt:P36578 RPL4  1 0.527 2
 UniProt:P61313 RPL15  1 0.527 2
 UniProt:Q9Y4E5 ZN451      0.527 2
 UniProt:P27635 RPL10  1 0.527 2
 UniProt:Q9UN86 G3BP2  1 0.527 2
 UniProt:P38398 BRCA1  20 0.524 3
 UniProt:O14497-1 ARID1A      0.499 2
 UniProt:P13569 CFTR  17 0.483 8
 UniProt:P06748 NPM1  11 0.483 2
 UniProt:P03372 ESR1  10 0.462 2
 UniProt:P42768 WAS  2 0.462 2
Cite Us!